Home
Resources
Publications
Impact of Meriolins, a New Class of Cyclin-Dependent Kinase Inhibitors, on Malignant Glioma Proliferation and Neo-Angiogenesis

Impact of Meriolins, a New Class of Cyclin-Dependent Kinase Inhibitors, on Malignant Glioma Proliferation and Neo-Angiogenesis

Marie Jarry, Céline Lecointre, Céline Malleval, Laurence Desrues, Marie-Thérèse Schouft, Vadim Lejoncour, François Liger, Gildas Lyvinec, Benoît Joseph, Nadège Loaëc, Laurent Meijer, Jérôme Honnorat, Pierrick Gandolfo, etc.

Neuro Oncol. 2014 Nov;16(11):1484-98.

PMID: 24891448

Abstract:

Background:
Glioblastomas are the most frequent and most aggressive primary brain tumors in adults. The median overall survival is limited to a few months despite surgery, radiotherapy, and chemotherapy. It is now clearly established that hyperactivity of cyclin-dependent kinases (CDKs) is one of the processes underlying hyperproliferation and tumoral growth. The marine natural products meridianins and variolins, characterized as CDK inhibitors, display a kinase-inhibitory activity associated with cytotoxic effects. In order to improve selectivity and efficiency of these CDK inhibitors, a series of hybrid compounds called meriolins have been synthesized.
Methods:
The potential antitumoral activity of meriolins was investigated in vitro on glioma cell lines (SW1088 and U87), native neural cells, and a human endothelial cell line (HUV-EC-C). The impact of intraperitoneal or intratumoral administrations of meriolin 15 was evaluated in vivo on 2 different nude mice-xenografted glioma models.
Results:
Meriolins 3, 5, and 15 exhibited antiproliferative properties with nanomolar IC50 and induced cell-cycle arrest and CDK inhibition associated with apoptotic events in human glioma cell lines. These meriolins blocked the proliferation rate of HUV-EC-C through cell cycle arrest and apoptosis. In vivo, meriolin 15 provoked a robust reduction in tumor volume in spite of toxicity for highest doses, associated with inhibition of cell division, activation of caspase 3, reduction of CD133 cells, and modifications of the vascular architecture.
Conclusion:
Meriolins, and meriolin 15 in particular, exhibit antiproliferative and proapoptotic activities on both glioma and intratumoral endothelial cells, constituting key promising therapeutic lead compounds for the treatment of glioblastoma.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
IAR42417812	Meriolin 2			Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: